FREE Shippingto US, AU, UK and EU on all orders over $149

Emoksi-Optic 5 ml 1% eye drops




Release form, structure and pack
of the Drop eye 1% colourless or slabookrashenny, slightly opalescent.
1 ml of a metiletilpiridinol hydrochloride (emoksipin) 10 mg.
Excipients: sodium sulfite anhydrous, Natrium benzoicum, potassium dihydrophosphate (potassium phosphate monosubstituted), hydrophosphate sodium dodecahydrate (sodium phosphate disubstituted 12-water), methyl cellulose, water for and.
The Kliniko-pharmakologichesky
Drug group, stimulating processes of regeneration for topical administration in ophthalmology. Pharmacological action
the Antioxidant product interfering peroxide oxidation of lipids of cellular membranes. Has angioprotektorny, antiagregantny and anti-hypoxemic activity.
Reduces permeability of capillaries and strengthens a vascular wall (angioprotektorny action). Reduces viscosity of blood and aggregation of thrombocytes (antiagregantny action). Inhibits education of free radicals (antioxidant action). Possesses membrane stabilizing action. Increases resistance of fabrics to the shortage of oxygen (anti-hypoxemic action).
Has retinoprotektorny properties, protects a retina and other tissues of an eye from the damaging effect of light of high intensity. Promotes resorption of intraocular hemorrhages, reduces blood clotting, improves microcirculation of an eye. Stimulates reparative processes in a cornea (including in early in posledstviioperatsionny and in the posledstviiranevy period).
The pharmacokinetics
Quickly gets into bodies and fabrics where there is its deposition and metabolism. In eye tissues the concentration is higher, than in blood.
5 metabolites provided by the dialkylated and conjugated transmutation products Are revealed. Metabolites are excreted by kidneys. In significant amounts in hepatic fabric 2-ethyl-6-methyl-3-oxypyridine-phosphate is found.
Indications of a product

of hemorrhage in an anterior chamber of an eye (treatment),

hemorrhages in a sclera at elderly people (treatment and prevention),

inflammations and burns of a cornea (treatment and prevention),

complications in short-sightedness (treatment),

protection of a cornea (when carrying contact lenses)
the dosing Mode
appoint the Drug Emoksi-optik the adult. Dig in in a conjunctival sac on 1-2 drops 2-3
Course of treatment of 3-30 days. At need and good tolerance the course of treatment can be continued up to 6 months and 2-3 times a year can repeat.
Side effect
Local reactions: the burning sensation, an itching, short-term hyperaemia of a conjunctiva, is not frequent – local allergic reactions.
Contraindications to use of a product


the period of a lactation (breastfeeding),

children’s and teenage age up to 18 years,

hyper susceptibility to product components.
Pregnancy and a lactation
Drug is contraindicated at pregnancy and in the period of a lactation (breastfeeding).
Special instructions
At need of simultaneous use of other eye drops dig in a product in posledstviidny, in a consequence of full absorption of the previous drops (not less, than in 10-15 min.).
The overdose
Overdose of the Emoksi-optik product is not established.
Medicinal interaction
the Drug Emoksi-optik should not be mixed with other medicines.
Prescription status
Drug is released on the prescription.
Conditions and storage period
List B. Drug should be stored in the inaccessible for kids, protected from light place at a temperature not above 25 °C. The validity period – 2 years.
After opening of a bottle the product should be used for 1 month.

Additional information



There are no reviews yet.

Be the first to review “Emoksi-Optic 5 ml 1% eye drops”

Your email address will not be published.